We are live on
!
Find out more
GC
Grace Capital Portfolio holdings
AUM
$168M
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter
Est. Return
+18.02%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$256M
AUM Growth
+$40.8M
(+19%)
Cap. Flow
+$11.8M
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
25.74%
Holding
236
New
24
Increased
57
Reduced
82
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$8.05M |
| 2 |
IBM
IBM
|
+$3.95M |
| 3 |
Vanguard Health Care ETF
VHT
|
+$3.42M |
| 4 |
Vanguard Consumer Discretionary ETF
VCR
|
+$3.18M |
| 5 |
Vanguard Communication Services ETF
VOX
|
+$3.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$4.09M |
| 2 |
Gentex
GNTX
|
+$1.95M |
| 3 |
SiriusXM
SIRI
|
+$1.89M |
| 4 |
VeriSign
VRSN
|
+$1.63M |
| 5 |
Novartis
NVS
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.16% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 9.69% |
| 4 | Consumer Discretionary | 8.9% |
| 5 | Communication Services | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
State Street Health Care Select Sector SPDR ETF
XLV
$42.3B
| – | – |
-900
| Closed | -$78K |
|
|
CLDR
227
DELISTED
Cloudera, Inc.
CLDR
| – | – |
-27,682
| Closed | -$306K |
|
|
GRUB
228
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| – | – |
-5,451
| Closed | -$837K |
|
|
LOGM
229
DELISTED
LogMein, Inc.
LOGM
| – | – |
-14,978
| Closed | -$1.22M |
|
|
WP
230
DELISTED
Worldpay, Inc.
WP
| – | – |
-7,575
| Closed | -$579K |
|
|
NFX
231
DELISTED
Newfield Exploration
NFX
| – | – |
-6,400
| Closed | -$94K |
|
|
UBA
232
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| – | – |
-19,240
| Closed | -$370K |
|
Similar funds
REMS
TI
NM
KM
MC
FAC
MSO
ACM
Grace Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Grace Capital held 236 positions worth $256M, up 19% from $215M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Grace Capital deployed $11.8M of net new capital in Q1 2019, opening 24 new positions and adding to 57 existing holdings. Its largest new stake was IBM: 30,988 shares worth $4.18M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was MyoKardia, Inc. Common Stock, an estimated $4.09M trimmed.
- Grace Capital's largest Q1 2019 buy was IBM: 30,988 shares worth $4.18M.
- Grace Capital added most to Global Blood Therapeutics, Inc. in Q1 2019, an estimated $8.05M increase.
- Grace Capital's biggest Q1 2019 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $4.09M.
- Grace Capital fully exited Gentex in Q1 2019, selling an estimated $1.95M.
- Grace Capital's ten largest holdings make up 26% of its $256M portfolio in Q1 2019.
- Grace Capital opened 24 new positions and closed 36 in Q1 2019.
- Grace Capital's portfolio value rose 19% quarter-over-quarter to $256M.
Based on Grace Capital's 13F filing for Q1 2019, filed 15 May 2019.